TrialPanorama/TrialPanorama-database huggingface dataset:
Study 33407947 — Surrogate Endpoint (SUR): Blood pressure
Study 33407947 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33408185 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 33408199 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33408796 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study 33408874 — Surrogate Endpoint (SUR): Blood pressure
Study 33409402 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33409402 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33409402 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 33409402 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 33409402 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33410109 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33410109 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 33410356 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study 33410523 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 33410970 — Safety Biomarker (SAF): Arginase-1
Genes: ARG1
Study 33410970 — Predictive Biomarker (PRD): ARG2 mRNA
Genes: ARG2
Study 33411755 — Predictive Biomarker (PRD): TIMP2 mRNA
Genes: TIMP2
Study 33411755 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study 33411897 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 33412162 — Predictive Biomarker (PRD): MYO9A mRNA
Genes: MYO9A; MYR7
Study 33413552 — Surrogate Endpoint (SUR): Blood pressure
Study 33413574 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 33413574 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 33413574 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33415656 — Predictive Biomarker (PRD): BCAR1 mRNA
Genes: BCAR1; CAS; CASS1; CRKAS
Study 33417474 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33417511 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 33419423 — Predictive Biomarker (PRD): CORT mRNA
Genes: CORT; UNQ307/PRO350
Study 33419423 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 33419423 — Surrogate Endpoint (SUR): Blood pressure
Study 33420229 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 33420629 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33420629 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33422139 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 33422139 — Predictive Biomarker (PRD): GAL3ST1 mRNA
Genes: GAL3ST1; CST
Study 33426802 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33426802 — Predictive Biomarker (PRD): DNM1L mRNA
Genes: DNM1L; DLP1; DRP1
Study 33427211 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 33427211 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33427211 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 33427211 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 33427211 — Predictive Biomarker (PRD): Hormone receptor
Study 33428617 — Safety Biomarker (SAF): Hydroxyphenylpyruvate dioxygenase
Genes: HPD; PPD
Study 33428771 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 33431660 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study 33431660 — Predictive Biomarker (PRD): SIRPA mRNA
Genes: SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP
Study 33432705 — Safety Biomarker (SAF): Type I cytoskeletal 18 Keratin
Genes: KRT18; CYK18; PIG46
Study 33432705 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-122
Genes: MIR122
Study 33433149 — Predictive Biomarker (PRD): FTL mRNA
Genes: FTL
Study 33433155 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study 33433355 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 33433743 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 33433743 — Predictive Biomarker (PRD): Microsatellite instability
Study 33433743 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 33434161 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 33434314 — Surrogate Endpoint (SUR): Bone mineral density
Study 33435412 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 33435412 — Predictive Biomarker (PRD): NTRK
Study 33435695 — Monitoring Biomarker (MOI): Cell-free DNA
Study 33435865 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33436021 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study 33437832 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33437997 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 33437997 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33438092 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 33439382 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 33439382 — Predictive Biomarker (PRD): CBFA2T3 mRNA
Genes: CBFA2T3; MTG16; MTGR2; ZMYND4
Study 33439382 — Predictive Biomarker (PRD): GLIS2 mRNA
Genes: GLIS2; NKL
Study 33439382 — Predictive Biomarker (PRD): DEK mRNA
Genes: DEK
Study 33439382 — Predictive Biomarker (PRD): NUP214 mRNA
Genes: NUP214; CAIN; CAN; KIAA0023
Study 33439382 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 33439866 — Predictive Biomarker (PRD): ARHGEF5 mRNA
Genes: ARHGEF5; TIM
Study 33439866 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 33439866 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 33439866 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Chitinase-3-like protein 1
Genes: CHI3L1
Study 33439866 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33439866 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 33441102 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study 33441162 — Surrogate Endpoint (SUR): Pathological complete response
Study 33441362 — Surrogate Endpoint (SUR): Bone mineral density
Study 33441454 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 33441669 — Surrogate Endpoint (SUR): Blood pressure
Study 33442015 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 33442106 — Predictive Biomarker (PRD): PPY mRNA
Genes: PPY; PNP
Study 33446655 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33446655 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33448002 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33449605 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 33450703 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 33450703 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study 33450703 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study 33450703 — Predictive Biomarker (PRD): Hepatitis A virus cellular receptor 2
Genes: HAVCR2; TIM3; TIMD3
Study 33450703 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study 33450703 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33451977 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study 33452195 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33453199 — Surrogate Endpoint (SUR): Blood pressure
Study 33453294 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 33454291 — Surrogate Endpoint (SUR): Blood pressure
Study 33455928 — Surrogate Endpoint (SUR): Blood pressure
Study 33460002 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 33460002 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 33461313 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33463537 — Predictive Biomarker (PRD): SEC23A mRNA
Genes: SEC23A
Study 33463551 — Predictive Biomarker (PRD): IL21
Genes: Za11; IL-21
Study 33463681 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 33464575 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 33464621 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 33464953 — Surrogate Endpoint (SUR): Blood pressure
Study 33465252 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 33465704 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study 33467570 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 33467570 — Predictive Biomarker (PRD): NTRK
Study 33469058 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 33469058 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 33469058 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study 33469316 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study 33469662 — Predictive Biomarker (PRD): CFLAR mRNA
Genes: CFLAR; CASH; CASP8AP1; CLARP; MRIT
Study 33472397 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33472545 — Predictive Biomarker (PRD): ACTG1 mRNA
Genes: ACTG1; ACTG
Study 33472666 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33472687 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 33472687 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 33472687 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33472687 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 33472687 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 33472776 — Surrogate Endpoint (SUR): Blood pressure
Study 33475022 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 33476492 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33476575 — Predictive Biomarker (PRD): IRF4 mRNA
Genes: IRF4; MUM1
Study 33476575 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 33477979 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33478637 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 33478795 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 33478795 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 33478795 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33478795 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33478934 — Surrogate Endpoint (SUR): Serum creatinine
Study 33478934 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 33478934 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 33478934 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33479856 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 33480862 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 33480862 — Surrogate Endpoint (SUR): Bone mineral density
Study 33481403 — Predictive Biomarker (PRD): MPG mRNA
Genes: MPG; AAG; ANPG; MID1
Study 33482628 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study 33483920 — Surrogate Endpoint (SUR): Blood pressure
Study 33484559 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33484559 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33484559 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33484567 — Safety Biomarker (SAF): Hyaluronic acid
Study 33485079 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33486874 — Monitoring Biomarker (MOI): HBV DNA
Study 33487029 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33487127 — Surrogate Endpoint (SUR): Bone mineral density
Study 33487129 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33487129 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33487289 — Predictive Biomarker (PRD): ELN mRNA
Genes: ELN
Study 33487289 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study 33487289 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33487289 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33487468 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33489806 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33489806 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 33490196 — Predictive Biomarker (PRD): SOX21 mRNA
Genes: SOX21; SOX25; SOXA
Study 33490296 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 33491053 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33491277 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 33491668 — Predictive Biomarker (PRD): COL7A1 mRNA
Genes: COL7A1
Study 33491668 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study 33491668 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 33492239 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 33492438 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study 33493046 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 33493392 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 33493392 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 33493688 — Predictive Biomarker (PRD): MME mRNA
Genes: MME; EPN
Study 33493697 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study 33494793 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33494793 — Predictive Biomarker (PRD): GNAQ mRNA
Genes: GNAQ; GAQ
Study 33494963 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 33495309 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study 33495309 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 33495312 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study 33495312 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 33495476 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33495476 — Predictive Biomarker (PRD): Microsatellite instability
Study 33495752 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33496357 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33496747 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study 33496747 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study 33496747 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 33497524 — Predictive Biomarker (PRD): CLN3 mRNA
Genes: CLN3; BTS
Study 33498192 — Predictive Biomarker (PRD): SLC25A20 mRNA
Genes: SLC25A20; CAC; CACT
Study 33498797 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33498797 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33498797 — Predictive Biomarker (PRD): Hormone receptor
Study 33500704 — Monitoring Biomarker (MOI): HBV DNA
Study 33500784 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study 33501400 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33502111 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 33502111 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 33502567 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33503046 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 33503568 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33505995 — Surrogate Endpoint (SUR): Blood pressure
Study 33506571 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 33506766 — Monitoring Biomarker (MOI): Cell-free DNA
Study 33506990 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 33507454 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 33507454 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 33507803 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study 33507803 — Predictive Biomarker (PRD): MAGEA4 mRNA
Genes: MAGEA4; MAGE4
Study 33507822 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 33507832 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 33508469 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33508469 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 33508469 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33508469 — Monitoring Biomarker (MOI): Macrophage inflammatory protein 1-alpha
Genes: CCL3; G0S19-1; MIP1A; SCYA3
Study 33509135 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 33509215 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33509215 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 33509215 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33509259 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 33509259 — Predictive Biomarker (PRD): CDKN1B mRNA
Genes: CDKN1B; KIP1; p27
Study 33509972 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33510705 — Predictive Biomarker (PRD): TCFL5 mRNA
Genes: TCFL5; CHA; E2BP1
Study 33512057 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33512323 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 33512414 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 33512414 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33512414 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 33512452 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study 33512974 — Safety Biomarker (SAF): Hyaluronic acid
Study 33513026 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33513026 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 33513026 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33513935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33513935 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 33513935 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 33514428 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33515429 — Predictive Biomarker (PRD): CYBB mRNA
Genes: CYBB; NOX2
Study 33516215 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 33516248 — Predictive Biomarker (PRD): HPSE mRNA
Genes: HPSE; HEP; HPA; HPA1; HPR1; HPSE1; HSE1
Study 33517185 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 33517185 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 33518523 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33518523 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33519425 — Predictive Biomarker (PRD): MCIDAS mRNA
Genes: MCIDAS; IDAS; MCI; MCIN
Study 33520317 — Surrogate Endpoint (SUR): Serum creatinine
Study 33521522 — Surrogate Endpoint (SUR): Blood pressure
Study 33521534 — Surrogate Endpoint (SUR): Blood pressure
Study 33521539 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33521643 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study 33521643 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 33521643 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33522900 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 33522978 — Surrogate Endpoint (SUR): Blood pressure
Study 33523334 — Predictive Biomarker (PRD): CD37 mRNA
Genes: CD37; TSPAN26
Study 33524316 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33524399 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study 33524601 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33524990 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 33524990 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33526303 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 33526918 — Monitoring Biomarker (MOI): Complement C4
Study 33527447 — Predictive Biomarker (PRD): RAC1 mRNA
Genes: RAC1; TC25; MIG5
Study 33527447 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 33527447 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 33527447 — Predictive Biomarker (PRD): Epithelial cadherin
Genes: CDH1; CDHE; UVO
Study 33527447 — Predictive Biomarker (PRD): ITGA4 mRNA
Genes: ITGA4; CD49D
Study 33527447 — Predictive Biomarker (PRD): ITGB5 mRNA
Genes: ITGB5
Study 33527447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33527447 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study 33528045 — Predictive Biomarker (PRD): OCRL mRNA
Genes: OCRL; OCRL1
Study 33528118 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33528867 — Predictive Biomarker (PRD): CPT1A mRNA
Genes: CPT1A; CPT1
Study 33529058 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1